10/21/2026
A promising step forward in ovarian cancer research! 🧬🔬
University of Iowa researchers developed a new treatment that has received FDA clearance to advance to clinical trials. The treatment aims to convert immune cells that support ovarian cancer tumors into immune cells that kill them.
Contributors from UI Health Care and the UI Carver College of Medicine include physician-scientists George Weiner, MD, Annette Schlueter, MD, and Michael Goodheart, MD, research scientist Jyoti Arora, associate research scientist Melissa Fath, and Laura Dallas, Regulatory Affairs Specialist for Investigational Drugs and Devices at the Holden Comprehensive Cancer Center.
https://uiowa.pulse.ly/t3x3niegss